Last reviewed · How we verify
NCT03418077
Post-Exercise Cardiovascular Responses Following Energy Drink Consumption
NA trial testing Energy Drink in QTc Interval in 28 participants. Completed in 31 May 2019.
31 May 2019
Quick facts
| Lead sponsor | David Grant U.S. Air Force Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 28 |
| Start date | 7 May 2018 |
| Primary completion | 31 May 2019 |
| Estimated completion | 31 May 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Energy Drink
- Placebo-control — full drug profile →
Conditions studied
- QTc Interval — all drugs for QTc Interval →
Sponsor
David Grant U.S. Air Force Medical Center
Who can join
Adults 18 to 40, any sex, with QTc Interval. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to determine the effects of consuming an original flavor energy drink on electrocardiographic (ECG) and hemodynamic responses during and after exercise in healthy subjects. The effect of drinking an energy drink on exercise performance will also be evaluated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03418077
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Energy Drink
Trials testing the same drug.
- NCT06330649 — The Acute Effect of and Energy Drink vs. Water Consumption on MAP, HR, and Energy Metabolism · NA · completed
- NCT05503732 — Effects of Energy Drinks on Sleep and Cardiovascular Health · NA · completed
- NCT07104188 — Effects of Energy Drink on Repeated Sprint Performance and Cognitive Function in Athletes · NA · completed
- NCT03936712 — Effect of Energy Drink on Sport Performance and Psycho-Physiological Responses. · NA · completed
Other David Grant U.S. Air Force Medical Center trials
Trials by the same sponsor.
- NCT06955923 — Trigger Point Injection in Reducing Pain Following Total Knee Arthroplasty · Phase 2 · completed
- NCT06911359 — The Effect and Safety of Anti-inflammatories and Dextrose Prolotherapy Injections in Treating Knee Osteoarthritis · Phase 2 · recruiting
- NCT05071196 — Facilitated Vegan Diet on Cardiometabolic Endpoints and Trimethylamine N-oxide · NA · unknown
- NCT04604145 — Self-Collected Saliva Samples Without Viral Transport Media for COVID-19 Testing Via RT-PCR · NA · completed
- NCT04646642 — Psychological Health, Coping Strategies and Preferences of Military COVID-19 Deployers · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03418077 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by David Grant U.S. Air Force Medical Center
- Last refreshed: 17 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03418077.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing